IRIS UniCatt

Ruggeri, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.340
NA - Nord America 3.271
AS - Asia 2.122
SA - Sud America 420
AF - Africa 61
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 9.233
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.197
IT - Italia 1.277
SG - Singapore 956
DE - Germania 650
CN - Cina 540
BR - Brasile 344
SE - Svezia 335
UA - Ucraina 269
FR - Francia 238
VN - Vietnam 206
GB - Regno Unito 126
IE - Irlanda 117
IN - India 80
ID - Indonesia 76
FI - Finlandia 70
RU - Federazione Russa 60
TR - Turchia 55
CA - Canada 44
ES - Italia 34
HK - Hong Kong 34
BD - Bangladesh 33
NL - Olanda 32
BE - Belgio 26
AR - Argentina 24
CH - Svizzera 24
JP - Giappone 21
PL - Polonia 20
IR - Iran 18
ZA - Sudafrica 18
IQ - Iraq 17
EC - Ecuador 16
AT - Austria 15
PK - Pakistan 14
MX - Messico 12
VE - Venezuela 12
KR - Corea 10
TN - Tunisia 10
CO - Colombia 8
ET - Etiopia 8
UZ - Uzbekistan 8
AU - Australia 7
JO - Giordania 7
KZ - Kazakistan 7
PH - Filippine 7
RO - Romania 7
KE - Kenya 6
MA - Marocco 6
SA - Arabia Saudita 6
CL - Cile 5
EU - Europa 5
HR - Croazia 5
PT - Portogallo 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
GR - Grecia 4
HN - Honduras 4
KW - Kuwait 4
LB - Libano 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
EE - Estonia 3
EG - Egitto 3
JM - Giamaica 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
HU - Ungheria 2
IL - Israele 2
MD - Moldavia 2
MY - Malesia 2
MZ - Mozambico 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
AL - Albania 1
AQ - Antartide 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LR - Liberia 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
Totale 9.224
Salva come PNG Salva come JPEG
Città #
Chandler 434
Singapore 411
Ashburn 256
San Jose 235
Jacksonville 190
Milan 182
Ann Arbor 147
Plan 117
Dublin 115
Beijing 114
San Mateo 112
Cattolica 110
Nanjing 92
Rome 90
Woodbridge 76
Ho Chi Minh City 71
Jakarta 69
Wilmington 68
Bremen 67
Lauterbourg 61
Boston 60
Dearborn 59
Munich 59
Lawrence 57
Los Angeles 54
Mountain View 46
Hanoi 44
New York 44
Nanchang 42
Marseille 41
Seattle 40
Buffalo 39
Moscow 37
São Paulo 37
Hong Kong 31
Houston 29
Redwood City 27
Frankfurt am Main 26
Frattamaggiore 26
Turin 26
Izmir 25
Shanghai 25
Brussels 23
Paris 21
Boardman 19
Bari 17
Jiaxing 17
Lancaster 17
Redmond 17
Enterprise 16
Hebei 16
Tokyo 16
Bologna 15
Chicago 15
Kunming 15
Fairfield 14
Hangzhou 14
Changsha 13
Norwalk 13
Nürnberg 13
Orem 13
Augusta 12
Da Nang 12
Dallas 12
Detroit 12
Hefei 12
Torino 12
University Park 12
Brooklyn 11
Chennai 11
Guangzhou 11
Santa Clara 11
Atlanta 10
Falls Church 10
Fremont 10
Montreal 10
Princeton 10
Brasília 9
Como 9
Kish 9
Kraków 9
Mumbai 9
Napoli 9
Ottawa 9
Pune 9
Rio de Janeiro 9
Tianjin 9
Düsseldorf 8
Johannesburg 8
London 8
Taranto 8
Toronto 8
Warsaw 8
Zurich 8
Addis Ababa 7
Amman 7
Curitiba 7
Denver 7
Dhaka 7
Florence 7
Totale 4.561
Salva come PNG Salva come JPEG
Nome #
I costi socio-sanitari dell’insufficienza renale cronica 806
L'analisi dei network organizzativinei sistemi sanitari: il caso della rete di emergenza della Regione Lazio 398
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 230
Economia sanitaria 227
Cost Effectiveness Analysis of Instanyl for the Treatment of Breakthrough Cancer Pain (BtcP) 198
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use 188
Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy 185
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 182
Investigating the generalizability of Economic Evaluations conducted in Italy: a critical review 169
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 165
Healthcare expenditure on prevention in the spending review era 162
Il modello WEF per la valutazione economica delle innovazioni terapeutiche in epatologia. 158
Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals 157
Health Technology Assessment of the anti HCV strategies in Italy: evidences from the WEF Project 153
The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomy 148
A cost effectiveness analysis of cataract surgery 147
Cost effectiveness analysis of transnasal fentalyl citrate in the treatment of BTcP 144
Between rationing and rationalization. The challenges of the Italian National Health Service during the age of the great crisis 144
Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy. 143
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study. 139
Valutazione economica dei programmi di screening contro il cancro del colon retto: evidenze indirette di lungo periodo e sostenibilita` finanziaria in un’ottica di programmazione regionale 138
Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis 138
Harmonic study: A cost-effectiveness evaluation of ultrasonically activated shears for total thyroidectomy [Lo studio HARMONIC: Valutazione costo-efficacia dell'uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale] 137
Economic evaluation of screening programs for HCV: evidence from literature. 136
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 136
Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster 133
Do Probability and Certainty Equivalent techniques lead to inconsistent results? Evidence from gambles involving life years and quality of life. 130
Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults 127
Valutazione economica di Teysuno nel trattamento del Carcinoma gastrico avanzato 127
The cost-effectiveness of alternative strategies against HBV in Italy 125
Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort 125
Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines. 123
Cohort Of Hcv Patients In Italy: Sizing And Treatments In A Sample Of Italian Hepatology Centers. 122
A new decision model for economic evaluation of novel therapies for HCV 121
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory. 119
L’utilizzo di modelli decisionali per le valutazioni economiche dei farmaci in Italia: stato dell’arte e prospettive future 117
Come comunicare e trasferire i risultati delle valutazioni di HTA applicata alle vaccinazioni ai decision makers e agli stakeholders? il progetto dell’ISPOR Rome chapter 115
Clinical and economic evaluation of tapentadol ER and oxycodone/naloxone. 114
The minimum clinically important difference of the EQ-5D index. 113
New professional roles and patient satisfaction: evidence from a European survey along three clinical pathways 113
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 111
New Healthcare Professional Roles in Europe: a Survey of Patients' Experiences and Views in Nine Countries 111
Extending influenza vaccination to individuals aged 50–64: A budget impact analysis 110
Valutazione economica della tossina botulinica per la profilassi dell’emicrania cronica 110
Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis. 109
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 108
Valutazione economica di ranibizumab vs pegaptanib o vs terapia fotodinamica con verteporfina 106
Economic Assessment of an Anti-HCV Screening Program in Italy 103
Normative needs in healthcare: toward a new conceptualization of equity and capabilities. 103
Lo studio HARMONIC: valutazione costo-efficacia dell’uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale 102
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C 101
THE HARMONIC STUDY: COST-EFFECTIVENESS EVALUATION OF THE USE OF THE ULTRASONIC SCALPEL IN TOTAL THYROIDECTOMY. 98
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 98
Setting research priorities in the feld of emergency management: which piece of information are you willing to pay more? 97
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 96
Cost effectiveness studies in HIV treatment with Lopinavir/Ritonavir: a Review. 95
Analisi economica per l’estensione della vaccinazione contro l’influenza agli individui di età 50-64: risparmi sociali e analisi di Budget Impact 91
Introduction to essay health and economics 90
Cost-effectiveness analysis of Daclatasvir/Sofosbuvir for the treatment of the HCV patients failed after the first line with second generation of DAAs in Italy . 90
The cost effectiveness of Botox in Italian patients with chronic migraine. 89
Sevelamer Is Cost-Saving vs. Calcium Carbonate in Non-Dialysis-Dependent CKD Patients in Italy: A Patient-Level Cost-Effectiveness Analysis of the INDEPENDENT Study. 89
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study. 88
Cost effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C. 87
Valutazione dei costi delle infezioni nosocomiali da E.Coli in un policlinico romano di 1700 posti letto 86
Is risk attitude really specific within the health context domain? Further evidence from an Italian survey using Probability Equivalent technique and face to face interviews 72
Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review 71
Is risk outcome specific within the health domain? 66
Totale 9.329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.912
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 0 0 0 0 0 83 15
2021/2022677 58 68 20 27 31 26 54 108 30 43 84 128
2022/20231.319 147 186 96 223 91 170 56 113 163 17 46 11
2023/2024614 36 179 20 38 32 67 20 29 18 26 83 66
2024/20251.061 24 50 105 28 121 29 13 46 207 87 177 174
2025/20262.429 435 85 100 202 420 151 474 162 142 215 43 0
Totale 9.329